Penn Researchers Find Concurrent Treatment for Type 2 Diabetes and Depression Significantly Improves Both Conditions; Brief Adherence Programs Improve Diabetes Test Results and Depression SymptomsJANUARY 11, 2012
(PHILADELPHIA) – Patients simultaneously treated for both Type 2
diabetes and depression improve medication compliance and significantly
improve blood sugar and depression levels compared to patients
receiving usual care, according to a new study by researchers from the Perelman School of Medicine at the University of Pennsylvania.
Of patients receiving integrated care combined with a brief period of
intervention to assist with adherence to prescribed medication
regimens, more than 60 percent had improved blood sugar test results
and 58 percent had reduced depression symptoms, compared to only 36
percent and 31 percent, respectively, of patients receiving usual care.
The full results of the study are published in the January/February
issue of The Annals of Family Medicine.